GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » AfterNext HealthTech Acquisition Corp (NYSE:AFTR) » Definitions » Return-on-Tangible-Equity

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Return-on-Tangible-Equity : 6.07% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is AfterNext HealthTech Acquisition Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. AfterNext HealthTech Acquisition's annualized net income for the quarter that ended in Jun. 2023 was $14.92 Mil. AfterNext HealthTech Acquisition's average shareholder tangible equity for the quarter that ended in Jun. 2023 was $245.70 Mil. Therefore, AfterNext HealthTech Acquisition's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2023 was 6.07%.

The historical rank and industry rank for AfterNext HealthTech Acquisition's Return-on-Tangible-Equity or its related term are showing as below:

AFTR' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 3.67   Med: 4.3   Max: 4.3
Current: 3.67

During the past 2 years, AfterNext HealthTech Acquisition's highest Return-on-Tangible-Equity was 4.30%. The lowest was 3.67%. And the median was 4.30%.

AFTR's Return-on-Tangible-Equity is not ranked
in the Diversified Financial Services industry.
Industry Median: 0.68 vs AFTR: 3.67

AfterNext HealthTech Acquisition Return-on-Tangible-Equity Historical Data

The historical data trend for AfterNext HealthTech Acquisition's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AfterNext HealthTech Acquisition Return-on-Tangible-Equity Chart

AfterNext HealthTech Acquisition Annual Data
Trend Dec21 Dec22
Return-on-Tangible-Equity
- 4.30

AfterNext HealthTech Acquisition Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only 5.05 1.98 4.69 1.89 6.07

Competitive Comparison of AfterNext HealthTech Acquisition's Return-on-Tangible-Equity

For the Shell Companies subindustry, AfterNext HealthTech Acquisition's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AfterNext HealthTech Acquisition's Return-on-Tangible-Equity Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, AfterNext HealthTech Acquisition's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where AfterNext HealthTech Acquisition's Return-on-Tangible-Equity falls into.



AfterNext HealthTech Acquisition Return-on-Tangible-Equity Calculation

AfterNext HealthTech Acquisition's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2022 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=10.227/( (232.453+242.68 )/ 2 )
=10.227/237.5665
=4.30 %

AfterNext HealthTech Acquisition's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jun. 2023 )  (Q: Mar. 2023 )(Q: Jun. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jun. 2023 )  (Q: Mar. 2023 )(Q: Jun. 2023 )
=14.916/( (243.832+247.561)/ 2 )
=14.916/245.6965
=6.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


AfterNext HealthTech Acquisition  (NYSE:AFTR) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


AfterNext HealthTech Acquisition Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of AfterNext HealthTech Acquisition's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
301 Commerce Street, Suite 3300, City Fort Worth, TX, USA, 76102
Website
AfterNext HealthTech Acquisition Corp is a blank check company.
Executives
Jon Winkelried director, 10 percent owner C/O GOLDMAN, SACHS & CO., 85 BROAD STREET, NEW YORK NY 10004
Tpg Gp A, Llc director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
R Halsey Wise director, officer: Chief Executive Officer 135 PONTE VEDRA BLVD, PONTE VEDRA BEACH FL 32082
Julie L. Gerberding director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
David Bonderman director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
James G Coulter director, 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Tpg Group Holdings (sbs) Advisors, Inc. director, 10 percent owner C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Jeffrey K. Rhodes director C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Christopher H. Hunter director 500 W MAIN STREET, LOUISVILLE KY 40202
Bharat Sundaram director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Martin Davidson officer: Chief Financial Officer C/O TPG PACE ENERGY HOLDINGS CORP., 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Nehal Raj director C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Anthony Jr Colaluca director, officer: President MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
William Joseph Miller director 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Agneta G. Breitenstein director C/OAFTERNEXT HEALTHTECH ACQUISITION CORP, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Headlines